DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Organ Transplant Immunosuppressant Drugs Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
Organ transplant immunosuppressant drugs are the category of drugs which are administered to minimize the chances of organ rejection after transplantation. When a person undergoes any transplantation, the body recognizes the transplant as a foreign tissue and attacks it, resulting in rejection. These drugs dilute the immune system, hence reducing the reaction towards the transplant.
The factors driving this market include the advancements made in tissue engineering and organ transplantations. These transplantations help in survival of many patients as well as enhance the quality of life. The lack of availability of organs and high cost of transplantation are the limitations for the growth of this market. The increase in use of tissue engineering for generation of implants provides growth opportunity to this market.
Key Market Segments:
The global Organ transplant immunosuppressant drugs market is segmented into therapeutics, commercialized products and geography.
Market By Therapeutics:
- Heart Transplant
- Lung Transplant
- Kidney Transplant
- Liver Transplant
Market by Commercialized Products:
Market by Geography:
- North America
For more information about this report visit http://www.researchandmarkets.com/research/xw4k66/world_organ